The Global Health Observatory
Explore a world of health data
Appears in:
- HIV|
© WHO / Petterik Wiggers
Situation and trends
At the end of 2023, 77% [61–89%] of people living with HIV were accessing antiretroviral therapy, up from 24% [19–28%] in 2010.
- Globally, there were 1.2 million [950 000–1.4 million] pregnant women with HIV in 2023, of which an estimated 84% [72–>98%] received antiretroviral drugs to prevent mother-to-child transmission.
- At the end of 2023, there were 1.4 million [1.1–1.7 million] children living with HIV globally, down from 2.5 million [2.0–3.1 million] in 2010.
Summary findings
Prevention of vertical transmission
84%
of pregnant women with HIV received antiretroviral drugs to prevent mother-to-child transmission, globally in 2023
Antiretroviral therapy for children
57%
of children living with HIV were accessing antiretroviral therapy in 2023
Antiretroviral therapy access
77%
of people living with HIV were accessing antiretroviral therapy in 2023
Data on the HIV response
HIV, testing and counselling
HIV/AIDS response: Antiretroviral therapy coverage
HIV - Prevention of mother-to-child transmission
-
HIV – Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission -
HIV – Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
-
HIV – Estimated number of pregnant women living with HIV
HIV, Pediatric antiretroviral therapy coverage
More HIV data products
Related data and statistics
Related team
Global HIV Programme
The WHO Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes leads the development and implementation of the global health sector strategy on the elimination of HIV as a public health threat.